Peruvian economic watchdog INDECOPI has issued fines on five major drug store chains, having determined their involvement in a price-fixing scheme affecting 36 major medications, violating competition legislation and adversely affecting consumers.
Charges were presented against the Arcangel (Albis SA), Fasa (Farmacias Peruanas SA), Inkafarma (Eckerd Perú SA), Mifarma (Mifarma SA) and Felicidad (Nortfarma SAC) drug store chains, with fines totalling approximately $2,641,992 USD for their involvement in actions classed as ‘anticompetitive’ by Peru’s antitrust legislation.
As well as the economic sanctions mentioned, INDECOPI’s Commission for the Defense of Free Competition (CLC) has ordered the companies to design and implement a three-year program to avoid any relapse into uncompetitive behavior, including special training for sales personnel.
Full Content: Kaos en la Red
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Belgian Authorities Detain Multiple Individuals Over Alleged Huawei Bribery in EU Parliament
Mar 13, 2025 by
CPI
Grubhub’s Antitrust Case to Proceed in Federal Court, Second Circuit Rules
Mar 13, 2025 by
CPI
Pharma Giants Mallinckrodt and Endo to Merge in Multi-Billion-Dollar Deal
Mar 13, 2025 by
CPI
FTC Targets Meta’s Market Power, Calls Zuckerberg to Testify
Mar 13, 2025 by
CPI
French Watchdog Approves Carrefour’s Expansion, Orders Store Sell-Off
Mar 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Self-Preferencing
Feb 26, 2025 by
CPI
Platform Self-Preferencing: Focusing the Policy Debate
Feb 26, 2025 by
Michael Katz
Weaponized Opacity: Self-Preferencing in Digital Audience Measurement
Feb 26, 2025 by
Thomas Hoppner & Philipp Westerhoff
Self-Preferencing: An Economic Literature-Based Assessment Advocating a Case-By-Case Approach and Compliance Requirements
Feb 26, 2025 by
Patrice Bougette & Frederic Marty
Self-Preferencing in Adjacent Markets
Feb 26, 2025 by
Muxin Li